Letrozole-API

Letrozole-API
Product Description

  • High-quality active pharmaceutical ingredient designed for letrozole-based formulations.
  • Provided as a highly purified, white crystalline powder with consistent physicochemical properties.
  • Manufactured under strict cGMP conditions to ensure reliable quality and batch-to-batch reproducibility.
  • Extensively characterized using advanced analytical methods such as HPLC, NMR, and LC-MS for definitive identification.
  • Fully compliant with international pharmacopeial standards to guarantee pharmaceutical-grade performance.
  • Optimized for incorporation into oral dosage forms, ensuring predictable bioavailability and therapeutic efficacy.
  • Functions as a potent aromatase inhibitor, effectively reducing estrogen production in postmenopausal breast cancer patients.
  • Clinically validated with a well-established safety and efficacy profile in hormone receptor-positive breast cancer therapy.
  • EXAMON Handelsges.m.b.H.

    • AT
    • 2024
      On CPHI since
    Specifications
    • Selling Points
      Price; Product Features; Product Performance; Quality Service

    EXAMON Handelsges.m.b.H.

    • AT
    • 2024
      On CPHI since

    More Products from EXAMON Handelsges.m.b.H. (32)

    • Enoxaparin sodium-API

      Product Enoxaparin sodium-API

      • High-quality active pharmaceutical ingredient used in the production of low molecular weight heparin formulations. • Exhibits reliable anticoagulant activity with a favorable pharmacokinetic profile for clinical applications. • Manufactured under stringent cGMP conditions to guarantee exceptional puri...
    • Erlotinib hydrochloride-API

      Product Erlotinib hydrochloride-API

      • High-purity active pharmaceutical ingredient developed for erlotinib-based formulations. • Potent inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, essential for targeting aberrant cancer cell signaling. • Supplied as a fine crystalline powder with excellent physicochemical sta...
    • Fingolimod hydrochloride-API

      Product Fingolimod hydrochloride-API

      • High-quality active pharmaceutical ingredient developed for fingolimod-based formulations. • Potent modulator of sphingosine-1-phosphate receptors, crucial for managing relapsing multiple sclerosis. • Manufactured under strict cGMP conditions to ensure consistent quality and batch-to-batch reproducibi...
    • Gefitinib-API

      Product Gefitinib-API

      • High-quality active pharmaceutical ingredient developed for gefitinib-based formulations. • Selective EGFR tyrosine kinase inhibitor designed to block aberrant cancer cell signaling. • Offered as a fine, crystalline powder with excellent purity and consistent physicochemical properties. • Manufacture...
    • Imatinib Mesylate-API

      Product Imatinib Mesylate-API

      • Premium-grade active pharmaceutical ingredient intended for imatinib-based formulations. • Selectively targets the BCR-ABL tyrosine kinase, crucial for managing chronic myelogenous leukemia and gastrointestinal stromal tumors. • Supplied as a highly purified crystalline powder with excellent physicoch...
    • Lenalidomide hemihydrate-API

      Product Lenalidomide hemihydrate-API

      • High-quality active pharmaceutical ingredient designed for lenalidomide hemihydrate formulations. • Manufactured under stringent cGMP conditions to ensure batch-to-batch reproducibility and high quality. • Extensively characterized using advanced analytical techniques such as HPLC, NMR, and LC-MS for ...
    • Pazopanib hydrochloride-API

      Product Pazopanib hydrochloride-API

      • High-purity active pharmaceutical ingredient engineered for pazopanib-based formulations. • Offered as a fine crystalline powder with robust purity and consistent physicochemical properties. • Produced under rigorous cGMP standards to ensure batch-to-batch reproducibility and quality assurance. • Sub...
    • Sunitinib malate-API

      Product Sunitinib malate-API

      • High-quality active pharmaceutical ingredient developed for sunitinib-based formulations. • Provided as a fine crystalline powder with exceptional purity and consistent physicochemical attributes. • Manufactured under strict cGMP conditions to ensure uniform quality and batch-to-batch reproducibility....
    • Valganciclovir hydrochloride-API

      Product Valganciclovir hydrochloride-API

      • Premium-grade active pharmaceutical ingredient formulated for valganciclovir-based products • Supplied as a finely milled crystalline powder with exceptional purity and consistent quality • Produced under strict cGMP conditions to ensure reproducibility and high manufacturing standards • Extensively ...
    • Erlotinib-KIMOTAR®

      Product Erlotinib-KIMOTAR®

      • Erlotinib blocks the epidermal growth factor receptor’s tyrosine kinase to suppress tumor cell growth. • Validated efficacy in non-small cell lung cancer (first-line). • Offered in tablet form to facilitate patient-friendly, outpatient treatment. • Underpinned by a wide range of peer-reviewed studies...
    • Imatinib

      Product Imatinib

      • Targeted mechanism that selectively inhibits the BCR-ABL tyrosine kinase to disrupt signaling pathways driving abnormal cell growth in chronic myelogenous leukemia and gastrointestinal stromal tumors (first-line). • Clinically established with robust trials confirming its ability to control disease pro...
    • Gefitinib-GEFISA®

      Product Gefitinib-GEFISA®

      • Used for non-small cell lung cancer (NSCLC) as first-line therapy. Targets EGFR mutations to inhibit tumor growth. •  An EGFR tyrosine kinase inhibition which interrupts receptor signaling to limit tumor cell proliferation. • Robust clinical studies confirm benefits in non-small cell lung and pan...

    Frequently Viewed Together

    Recently Visited